| UniProt ID | PRR5_HUMAN | |
|---|---|---|
| UniProt AC | P85299 | |
| Protein Name | Proline-rich protein 5 | |
| Gene Name | PRR5 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 388 | |
| Subcellular Localization | ||
| Protein Description | Subunit of mTORC2, which regulates cell growth and survival in response to hormonal signals. mTORC2 is activated by growth factors, but, in contrast to mTORC1, seems to be nutrient-insensitive. mTORC2 seems to function upstream of Rho GTPases to regulate the actin cytoskeleton, probably by activating one or more Rho-type guanine nucleotide exchange factors. mTORC2 promotes the serum-induced formation of stress-fibers or F-actin. mTORC2 plays a critical role in AKT1 'Ser-473' phosphorylation, which may facilitate the phosphorylation of the activation loop of AKT1 on 'Thr-308' by PDK1 which is a prerequisite for full activation. mTORC2 regulates the phosphorylation of SGK1 at 'Ser-422'. mTORC2 also modulates the phosphorylation of PRKCA on 'Ser-657'. PRR5 plays an important role in regulation of PDGFRB expression and in modulation of platelet-derived growth factor signaling. May act as a tumor suppressor in breast cancer.. | |
| Protein Sequence | MRTLRRLKFMSSPSLSDLGKREPAAAADERGTQQRRACANATWNSIHNGVIAVFQRKGLPDQELFSLNEGVRQLLKTELGSFFTEYLQNQLLTKGMVILRDKIRFYEGQKLLDSLAETWDFFFSDVLPMLQAIFYPVQGKEPSVRQLALLHFRNAITLSVKLEDALARAHARVPPAIVQMLLVLQGVHESRGVTEDYLRLETLVQKVVSPYLGTYGLHSSEGPFTHSCILEKRLLRRSRSGDVLAKNPVVRSKSYNTPLLNPVQEHEAEGAAAGGTSIRRHSVSEMTSCPEPQGFSDPPGQGPTGTFRSSPAPHSGPCPSRLYPTTQPPEQGLDPTRSSLPRSSPENLVDQILESVDSDSEGIFIDFGRGRGSGMSDLEGSGGRQSVV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 6 (in isoform 2) | Phosphorylation | - | 45.39 | 30622161 | |
| 11 | Phosphorylation | LRRLKFMSSPSLSDL HHHHHCCCCCCHHHH | 42.08 | 30266825 | |
| 12 | Phosphorylation | RRLKFMSSPSLSDLG HHHHCCCCCCHHHHC | 13.51 | 30266825 | |
| 14 | Phosphorylation | LKFMSSPSLSDLGKR HHCCCCCCHHHHCCC | 42.31 | 30266825 | |
| 16 | Phosphorylation | FMSSPSLSDLGKREP CCCCCCHHHHCCCCC | 34.82 | 30266825 | |
| 20 | Acetylation | PSLSDLGKREPAAAA CCHHHHCCCCCCHHH | 61.97 | 12431423 | |
| 34 | Phosphorylation | ADERGTQQRRACANA HCHHHHHHHHHHHHC | 36.34 | 24719451 | |
| 35 | Phosphorylation | DERGTQQRRACANAT CHHHHHHHHHHHHCC | 20.53 | 27251275 | |
| 37 | Phosphorylation | RGTQQRRACANATWN HHHHHHHHHHHCCHH | 10.04 | 27251275 | |
| 77 | Phosphorylation | GVRQLLKTELGSFFT HHHHHHHHHHHHHHH | 36.09 | 24719451 | |
| 161 | Sumoylation | NAITLSVKLEDALAR CCEEEEEEHHHHHHH | 42.66 | - | |
| 161 | Sumoylation | NAITLSVKLEDALAR CCEEEEEEHHHHHHH | 42.66 | - | |
| 238 | Phosphorylation | EKRLLRRSRSGDVLA HHHHHHHCCCCCCCC | 25.10 | 23401153 | |
| 240 | Phosphorylation | RLLRRSRSGDVLAKN HHHHHCCCCCCCCCC | 40.36 | 30266825 | |
| 246 | Ubiquitination | RSGDVLAKNPVVRSK CCCCCCCCCCCCCCC | 58.59 | - | |
| 252 | Phosphorylation | AKNPVVRSKSYNTPL CCCCCCCCCCCCCCC | 17.84 | 23401153 | |
| 254 | Phosphorylation | NPVVRSKSYNTPLLN CCCCCCCCCCCCCCC | 25.51 | 23401153 | |
| 255 | Phosphorylation | PVVRSKSYNTPLLNP CCCCCCCCCCCCCCC | 27.13 | 30266825 | |
| 257 | Phosphorylation | VRSKSYNTPLLNPVQ CCCCCCCCCCCCCHH | 13.69 | 30266825 | |
| 263 | Phosphorylation | NTPLLNPVQEHEAEG CCCCCCCHHHCHHHH | 11.53 | 24719451 | |
| 275 | Phosphorylation | AEGAAAGGTSIRRHS HHHHHCCCCCEECCC | 16.15 | 24719451 | |
| 276 | Phosphorylation | EGAAAGGTSIRRHSV HHHHCCCCCEECCCC | 21.77 | 23927012 | |
| 277 | Phosphorylation | GAAAGGTSIRRHSVS HHHCCCCCEECCCCC | 19.85 | 26074081 | |
| 282 | Phosphorylation | GTSIRRHSVSEMTSC CCCEECCCCCCCCCC | 26.06 | 23401153 | |
| 284 | Phosphorylation | SIRRHSVSEMTSCPE CEECCCCCCCCCCCC | 25.35 | 23927012 | |
| 287 | Phosphorylation | RHSVSEMTSCPEPQG CCCCCCCCCCCCCCC | 24.11 | 23663014 | |
| 288 | Phosphorylation | HSVSEMTSCPEPQGF CCCCCCCCCCCCCCC | 26.77 | 23663014 | |
| 296 | Phosphorylation | CPEPQGFSDPPGQGP CCCCCCCCCCCCCCC | 56.91 | 28450419 | |
| 299 | Phosphorylation | PQGFSDPPGQGPTGT CCCCCCCCCCCCCCC | 53.37 | 24719451 | |
| 304 | Phosphorylation | DPPGQGPTGTFRSSP CCCCCCCCCCCCCCC | 56.53 | 27422710 | |
| 305 | Phosphorylation | PPGQGPTGTFRSSPA CCCCCCCCCCCCCCC | 26.45 | 24719451 | |
| 306 | Phosphorylation | PGQGPTGTFRSSPAP CCCCCCCCCCCCCCC | 20.53 | 27251275 | |
| 307 | Phosphorylation | GQGPTGTFRSSPAPH CCCCCCCCCCCCCCC | 8.25 | 27251275 | |
| 309 | Phosphorylation | GPTGTFRSSPAPHSG CCCCCCCCCCCCCCC | 36.16 | 30266825 | |
| 310 | Phosphorylation | PTGTFRSSPAPHSGP CCCCCCCCCCCCCCC | 22.33 | 30266825 | |
| 315 | Phosphorylation | RSSPAPHSGPCPSRL CCCCCCCCCCCCCCC | 43.29 | 26552605 | |
| 320 | Phosphorylation | PHSGPCPSRLYPTTQ CCCCCCCCCCCCCCC | 41.45 | 26552605 | |
| 325 | Phosphorylation | CPSRLYPTTQPPEQG CCCCCCCCCCCCCCC | 25.22 | 27251275 | |
| 326 | Phosphorylation | PSRLYPTTQPPEQGL CCCCCCCCCCCCCCC | 34.28 | 29449344 | |
| 327 | Phosphorylation | SRLYPTTQPPEQGLD CCCCCCCCCCCCCCC | 54.77 | 27251275 | |
| 333 | Phosphorylation | TQPPEQGLDPTRSSL CCCCCCCCCCCCCCC | 7.72 | 27251275 | |
| 336 | Phosphorylation | PEQGLDPTRSSLPRS CCCCCCCCCCCCCCC | 42.73 | 30266825 | |
| 338 | Phosphorylation | QGLDPTRSSLPRSSP CCCCCCCCCCCCCCH | 38.41 | 30266825 | |
| 339 | Phosphorylation | GLDPTRSSLPRSSPE CCCCCCCCCCCCCHH | 38.82 | 30266825 | |
| 343 | Phosphorylation | TRSSLPRSSPENLVD CCCCCCCCCHHHHHH | 48.59 | 27732954 | |
| 344 | Phosphorylation | RSSLPRSSPENLVDQ CCCCCCCCHHHHHHH | 37.20 | 27732954 | |
| 355 | Phosphorylation | LVDQILESVDSDSEG HHHHHHHHCCCCCCC | 27.98 | 27732954 | |
| 358 | Phosphorylation | QILESVDSDSEGIFI HHHHHCCCCCCCEEE | 40.66 | 27732954 | |
| 360 | Phosphorylation | LESVDSDSEGIFIDF HHHCCCCCCCEEEEC | 41.49 | 27732954 | |
| 362 | Phosphorylation | SVDSDSEGIFIDFGR HCCCCCCCEEEECCC | 24.86 | 24719451 | |
| 371 | Methylation | FIDFGRGRGSGMSDL EEECCCCCCCCCCCC | 34.44 | 115488975 | |
| 373 | Phosphorylation | DFGRGRGSGMSDLEG ECCCCCCCCCCCCCC | 29.93 | 29255136 | |
| 376 | Phosphorylation | RGRGSGMSDLEGSGG CCCCCCCCCCCCCCC | 42.44 | 29255136 | |
| 381 | Phosphorylation | GMSDLEGSGGRQSVV CCCCCCCCCCCCCCC | 28.79 | 29255136 | |
| 386 | Phosphorylation | EGSGGRQSVV----- CCCCCCCCCC----- | 24.40 | 29255136 | |
| 396 | Phosphorylation | --------------- --------------- | 27251275 | ||
| 404 | Phosphorylation | ----------------------- ----------------------- | 24719451 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 240 | S | Phosphorylation | Kinase | CHEK1 | O14757 | GPS |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PRR5_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PRR5_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| SIN1_HUMAN | MAPKAP1 | physical | 17461779 | |
| MTOR_HUMAN | MTOR | physical | 17461779 | |
| RICTR_HUMAN | RICTOR | physical | 17461779 | |
| LST8_HUMAN | MLST8 | physical | 17461779 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11, AND MASSSPECTROMETRY. | |